The Future of Healthcare Starts with Uncovering the Gut.
An ingestible capsule with automated sampling for precise, high-resolution small intestine data, eliminating invasive and inaccurate procedures for good.
A new standard of precision diagnostics
Microvitality’s ingestible capsule non-invasively collects samples directly from the small intestine. By accessing this previously unreachable region, the technology generates region-specific data that has never been routinely available, enabling clearer insights into disease mechanisms, more precise diagnostics, and targeted treatment decisions.
The small intestine is the most dynamic and bioactive region of the gut yet remains unexplored.
It is implicated in a wide range of gastrointestinal disorders, with systemic effects that extend beyond the gut.
TECHNOLOGY
Most methods fail to access the small intestine. Microvitality does, non invasively.
Much of what we know about the gut microbiome is derived from stool samples, which primarily reflect the colon and fail to accurately represent the microbial communities of the small intestine, where bacterial populations differ significantly.
OUTER CAPSULE
Protects the capsule from the acidic environment of the stomach, allowing it to safely transit through the gastrointestinal tract and reach the small intestine.
INNER CAPSULE
Autonomously collects a sample from the small intestine, using the peristaltic nature of the gut.
OUR ADVANTAGE
Precise sampling & flexible design
01
pH Activation and self-locking mechanism.
Our proprietary design activates sampling only upon reaching the small intestine, preventing premature collection. Once the sample is captured, the capsule securely seals to preserve integrity and minimize contamination during transit.
02
Flexible and size-adaptable design
Our capsule is flexible and compressible in nature, enhancing patient comfort and safety during ingestion and transit. Its adaptable sizing supports both adult and pediatric use without compromising performance.
A simple process powered by advanced science
Ingestion
Swallow the capsule as you would any other pill.
Sample
The capsule safely travels through the gastrointestinal tract and autonomously collects a sample from the small intestine
Retrieval
Retrieve the capsule using the collector in Microvitality’s kit and ship securely back to the lab.
Analysis
The sample is processed and analyzed to generate actionable insights.
Biomarker Discovery
Discover and validate novel microbiome biomarkers from the small intestine.
Host-microbiome research
Precise sampling for early detection and diagnosis of GI diseases.
Diagnostics
Access the small intestine to refine diagnosis and monitor treatment efficacy.
Gut-brain axis
Explore the relationship between the small intestine and neurological conditions.
Nutrition
Correlate products and dietary interventions to the unique small intestine environment.
Precision medicine
Optimize clinical trials and treatment efficacy using pharmaco-microbiomics profiling.
Proven in the lab.
Validated by the ecosystem.
3
Large Animal Models Deployed
NSR/IRB
Approved for in-human use
High
Correlation to Endoscopy Data
Samples from large animal models showed microbial signatures distinct from stool and closely resembled postmortem collections from the small intestine.
MEET THE FOUNDERS
We are on a mission to revolutionize gut health by leveraging the power of the microbiome.
PARTNERS
Driving Research Forward
We are seeking collaborators to expand the reach and impact of our technology. We welcome partnerships with clinicians, researchers, biotechnology and pharmaceutical companies who share our vision of advancing small intestine diagnostics and generating high-quality microbiome data to improve patient care and scientific discovery.
01
Access to Novel Data
Direct, region-specific sampling of the small intestine to generate high-resolution biological data previously out of reach.
02
Translational Impact
Turn high-resolution microbiome data into clinically meaningful insights that support biomarker discovery, improved diagnostics, and targeted therapeutic strategies.
03
Study Efficiency
Reduce reliance on invasive procedures and indirect tests, enabling faster study enrollment, streamlined workflows, and more efficient clinical studies.
